Skip to main content

Table 3 Side-effects following endobronchial infusion of the adipose derived stromal cells-stromal vascular fraction (ADSCs-SVF) in patients with IPF (n=14)

From: A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis

Side-effects

Number of patients (%)

Fever

7 (50%)

Worsening of cough

2 (14%)

Worsening of dyspnea

2 (14%)

Oxygen desaturations

2 (14%)

Cardiac abnormalities

0

Allergic reactions

0

Infections

0

Liver abnormalities

0

Renal abnormalities

0

Acute exacerbation/Hospitalization

0

Deaths

0

Ectopic tissue formation (24 months follow-up)

0

  1. Abbreviations: IPF Idiopathic pulmonary fibrosis.